Internal Medicine, Hematology & Oncology · Athens, GA
NPI
1306041900
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3320 Old Jefferson Rd Bldg 800
Athens, GA, 30607
Phone (706) 353-2990
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.4M
174,448 services
Medicare patients, 2024
901
Average age 75
Drug cost, 2024
$9.5M
2,728 prescriptions
Company payments, 2025
$1,793
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Petros G Nikolinakos was code J9271 (injection, pembrolizumab, 1 mg), 17,200 times for 22 patients. In total Petros G Nikolinakos billed 174,448 services in 218 codes, and Medicare paid $6.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 17,200 | 22 | $44.80 | $771K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,720 | 12 | $39.26 | $382K |
| J0897 Injection, denosumab, 1 mg | Office | 8,280 | 53 | $19.86 | $164K |
| A9607 Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | Office | 8,164 | 14 | $204.81 | $1.7M |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 6,325 | 23 | $6.27 | $40K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,293 | 48 | $15.88 | $84K |
| J9267 Injection, paclitaxel, 1 mg | Office | 4,489 | 12 | $0.08 | $345 |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 4,200 | 12 | $8.55 | $36K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,986 | 83 | $0.09 | $354 |
| 99214 Office E&M - Established | Office | 1,804 | 606 | $89.57 | $162K |
| 85025 Blood Count | Office | 1,299 | 472 | $7.59 | $9,859 |
| 36415 Venipuncture Blood Collection | Office | 1,287 | 486 | $8.62 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 683 | 86 | $20.04 | $14K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 664 | 31 | $0.07 | $49.27 |
| 96372 Injection Administration | Office | 629 | 158 | $9.88 | $6,212 |
By year: 2022 $6.7M for 240,524 services; 2023 $7.4M for 214,715 services; 2024 $6.4M for 174,448 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,299 | 472 | $7.59 | $9,859 |
| 36415 Venipuncture Blood Collection | 1,287 | 486 | $8.62 | $11K |
| 84550 Clinical Chemistry | 507 | 295 | $4.42 | $2,242 |
| 83615 Clinical Chemistry | 507 | 295 | $5.91 | $2,996 |
| 80053 Clinical Chemistry | 474 | 286 | $10.33 | $4,897 |
| 82728 Clinical Chemistry | 157 | 119 | $13.36 | $2,098 |
| 83550 Clinical Chemistry | 151 | 113 | $8.57 | $1,294 |
| 83540 Clinical Chemistry | 151 | 113 | $6.34 | $957 |
| 82784 Immunoassay | 135 | 30 | $9.11 | $1,230 |
| 83883 Clinical Chemistry | 134 | 38 | $13.33 | $1,786 |
Medicare prescription drug claims, 2024
In 2024, the drug Petros G Nikolinakos prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 216 prescriptions and refills. In total Petros G Nikolinakos wrote 2,728 Medicare prescriptions that cost $9.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 216 | 216 | 19 | $255K |
| Anastrozole Generic | 165 | 356 | 42 | $3,232 |
| Xtandi Enzalutamide | 101 | 108 | 15 | $1.4M |
| Eliquis Apixaban | 95 | 128 | 23 | $71K |
| Revlimid Lenalidomide | 82 | 82 | Under 11 | $1.4M |
| Prednisone Generic | 73 | 73 | 23 | $209 |
| Venclexta Venetoclax | 72 | 72 | Under 11 | $334K |
| Acyclovir Generic | 70 | 88 | 12 | $609 |
| Gabapentin Generic | 67 | 83 | 13 | $564 |
| Xgeva Denosumab | 59 | 86 | 12 | $186K |
| Exemestane Generic | 48 | 66 | Under 11 | $4,586 |
| Potassium Chloride Generic | 47 | 51 | 12 | $523 |
| Oxycodone Hcl Generic | 44 | 44 | 19 | $719 |
| Xarelto Rivaroxaban | 43 | 93 | 14 | $52K |
| Dexamethasone Generic | 41 | 43 | 22 | $811 |
Brand drugs: 1,266 claims; generic drugs: 1,462 claims; opioid claims: 137.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Petros G Nikolinakos $1,793 ($1,793 in general payments such as food, travel and fees) from 34 companies. The largest payer was GlaxoSmithKline, LLC. with $171.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 9 | $171 |
| Jazz Pharmaceuticals Inc. JAZZ | 7 | $154 |
| Pfizer Inc. PFE | 9 | $153 |
| Gilead Sciences, Inc. GILD | 6 | $142 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $137 |
| Intuitive Surgical, Inc. ISRG | 1 | $120 |
| Merck Sharp & Dohme LLC MRK | 5 | $117 |
| Array Biopharma Inc PFE | 10 | $101 |
| Abbvie Inc. ABBV | 4 | $95.77 |
| Stemline Therapeutics Inc. | 4 | $90 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.